Feasibility and Timing of Cytoreduction Surgery in Advanced (Metastatic or Recurrent) Gastrointestinal Stromal Tumors During the Era of Imatinib

The prognosis of advanced gastrointestinal stromal tumors (GISTs) was dramatically improved in the era of imatinib. Cytoreduction surgery was advocated as an additional treatment for advanced GISTs, especially when patients having poor response to imatinib or developing resistance to it. However, th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Medicine (Baltimore)
Autors principals: Chang, Shih-Chun, Liao, Chien-Hung, Wang, Shang-Yu, Tsai, Chun-Yi, Chiang, Kun-Chun, Cheng, Chi-Tung, Yeh, Ta-Sen, Chen, Yen-Yang, MA, Ming-Chun, Liu, Chien-Ting, Yeh, Chun-Nan
Format: Artigo
Idioma:Inglês
Publicat: Wolters Kluwer Health 2016
Matèries:
5700
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4616552/
https://ncbi.nlm.nih.gov/pubmed/26091448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000001014
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars